Back

Ophthalmic complications in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin

25 April 2021 (20:05 - 21:00)
Organised by:
Congress Presentation Part of: Treatment of atrial fibrillation and stroke prevention Oral Anticoagulation EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Olivia Costa

University of Connecticut, Storrs (United States of America)

6 More presentations in this session

Presentation thumbnail
Incidence and location of residual gaps identified by a high-density grid-style catheter after PVI is confirmed by pacing the ablation lines
Doctor S. Sundaram (Littleton, US)
Abstract Slides Video
Presentation thumbnail
Catheter ablation outscores all other treatment modalities in reducing all-cause mortality and heart failure related morbidity in patients of persistent atrial fibrillation with systolic heart failure
Doctor D. Khanra (CHESTER, GB)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of a high power short duration ablation-index guided protocol for pulmonary vein isolation using a single catheter
Doctor P. Badertscher (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Shorter interlesion distance is associated with a longer procedure time but not with poorer acute results of pulmonary vein isolation: results from a prospective ablation index registry
Doctor N. Gasimova (Saint Petersburg, RU)
Abstract Slides Video
Presentation thumbnail
Is the optimal blanking period duration after cryoballoon pulmonary vein isolation impacted by use of antiarrhythmic drugs?
Doctor D. Musat (Paramus, US)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment of atrial fibrillation and stroke prevention

The Event

Event poster

EHRA 2021

25 April 2021 20:05 CET
You may be interested in
thumbnail
Congress Presentation
Meta-analysis comparing the efficacy and safety of direct acting oral anticoagulants to warfarin in patients with atrial fibrillation with and without diabetes
28 August 2020
thumbnail
Congress Presentation
Predictors of bleeding complications during hospitalization in patients with atrial fibrillation who underwent transcatheter aortic valve replacement
29 June 2021
thumbnail
Congress Presentation
Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry- is dosing according to renal function appropriate?
27 August 2021
thumbnail
Congress Presentation
Oral anticoagulation in 13,344 adult patients with congenital heart disease (ACHD) in a longitudinal real-world setting in 2005-2017
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources